metformin/sitagliptin; januvia/metformin (Janumet)
Jump to navigation
Jump to search
Indications
- treatment of diabetes mellitus type 2
Contraindications
- renal failure: eGFR < 30 mL/min/1.73 m2
- metabolic acidosis
- not for use in treatment of diabetes mellitus type 1
Dosage
- BID dosing
- 50 mg sitagliptin + 500 mg or 1000 mg metformin
More general terms
Components
References
- ↑ Prescriber's Letter 14(5): 2007 Januvia's Place in Therapy Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230511&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ Highlights of Prescribing Information JanuMet <TM> (sitagliptin & metformin extended release) for oral use https://www.merck.com/product/usa/pi_circulars/j/janumet/janumet_pi.pdf
Highlights of Prescribing Information JanuMet XR <TM> (sitagliptin & metformin hydrochloride) for oral use https://www.merck.com/product/usa/pi_circulars/j/janumet_xr/janumet_xr_pi.pdf